Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO32). We employs the pGEX (pBAD-YFP-TFIIB-XbaI) vector components and the SynExpress system of the exons Inversion/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO32
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
pBAD
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
pGEX
Transformation Accuracy
0.97
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.